KOMO News has posted a story on the recent premarket approval by the Food & Drug Administration of a device designed to detect and treat epilepsy.
The story quotes Ryder Gwinn, M.D., medical director of the Swedish Neurosciences Institute Center for Neuromodulation and Functional Restoration
Testing on the NeuroPace device began in 2004 and was conducted throughout the United States, including the Swedish Neuroscience Institute. Today, Swedish is the only center in the Pacific Northwest approved to implant the device.
Read the full story on KOMOnews.com.